Carotid intima-media thickness in pediatric type 1 diabetic patients

Rocio Rabago Rodriguez1, Rita A Gómez-Díaz, Janet Tanus Haj

  • 1Servicio de Endocrinología, UMAE Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Diabetes Care
|July 24, 2007
PubMed

Insights

Pediatric type 1 diabetes is linked to increased carotid artery intima-media thickness (cIMT) and reduced blood flow velocities in Hispanic children. This suggests early vascular changes in young patients with type 1 diabetes.

Area of Science:

  • Cardiovascular Health
  • Pediatric Endocrinology
  • Medical Imaging

Background:

  • Type 1 diabetes (T1D) is a chronic condition affecting children, with potential long-term cardiovascular implications.
  • Early detection of vascular changes in pediatric T1D is crucial for timely intervention.
  • Hispanic populations may have unique risk factors or disease progression patterns.

Purpose of the Study:

  • To compare carotid artery intima-media thickness (cIMT) in Hispanic pediatric patients with type 1 diabetes versus healthy controls.
  • To assess potential differences in carotid blood flow velocities between the two groups.
  • To investigate early subclinical atherosclerosis markers in pediatric T1D.

Main Methods:

  • Carotid Doppler and real-time ultrasound were used to measure cIMT, peak systolic velocity, and end diastolic velocity.
  • Participants were Hispanic children, with cases having type 1 diabetes and controls being healthy, matched for age, sex, height, and BMI.
  • Biochemical parameters and anthropometric measurements were also collected.

Main Results:

  • A significantly higher cIMT was observed in children with type 1 diabetes compared to healthy controls (0.463 +/- 0.04 mm vs. 0.441 +/- 0.04 mm, P = 0.001).
  • Peak systolic velocity and end diastolic velocity were significantly lower in the type 1 diabetes group.
  • No significant differences in baseline characteristics (age, sex, height, BMI, blood pressure) were found between groups.

Conclusions:

  • Type 1 diabetes is associated with increased cIMT in Hispanic pediatric patients, indicating early vascular remodeling.
  • Decreased carotid blood flow velocities in pediatric T1D patients suggest impaired vascular function.
  • These findings highlight the importance of monitoring vascular health in children with type 1 diabetes.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...